A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)

Clinical trial NCT06072430 · RECRUITING

Trial details

NCT number: NCT06072430
Sponsor: Vivacelle Bio
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Septic Shock Sepsis Hypovolemia

Start date: 2024-08-06
Primary completion: 2025-12-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.